Glutathione-S-transferases as determinants of cell survival and death

Antioxidants and Redox Signaling

Volumn 17, Issue 12, 2012, Pages 1728-1737

  Tew, Kenneth D ^a   Townsend, Danyelle M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; CYSTEINE; CYTOKINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN E6; PROTEIN E7; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANTIOXIDANT ACTIVITY; CARCINOGENESIS; CATALYSIS; CELL DEATH; CELL METABOLISM; CELL SURVIVAL; COCAINE DEPENDENCE; DETOXIFICATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; GENE PRODUCT; GENETIC MODEL; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; MITOGENESIS; NERVE CELL PLASTICITY; NITROSATIVE STRESS; NONHUMAN; ONCOGENE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS TRANSMISSION;

ANIMALS; CELL DEATH; CELL SURVIVAL; GLUTATHIONE TRANSFERASE; HUMANS; MODELS, BIOLOGICAL;

EID: 84867733514     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4640     Document Type: Review

References (58)

1. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, and Ronai Z. Regulation of JNK signaling by GSTp. EMBO J 18: 1321-1334, 1999.. (Pubitemid 29110316)
2. Alcaraz LD, Olmedo G, Bonilla G, Cerritos R, Hernandez G, Cruz A, Ramirez E, Putonti C, Jimenez B, Martinez E, Lopez V, Arvizu JL, Ayala F, Razo F, Caballero J, Siefert J, Eguiarte L, Vielle JP, Martinez O, Souza V, Herrera-Estrella A, and Herrera-Estrella L. The genome of Bacillus coahuilensis reveals adaptations essential for survival in the relic of an ancient marine environment. Proc Natl Acad Sci U S A 105: 5803-5808, 2008.. (Pubitemid 351758453)
3. Ali-Osman F, Akande O, Antoun G, Mao JX, and Buo-lamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272: 10004-10012, 1997.. (Pubitemid 27171673)
4. Arner ES and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem/FEBS 267: 6102-6109, 2000..
5. Awasthi YC, Ansari GA, and Awasthi S. Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases. Methods Enzymol 401: 379-407, 2005.. (Pubitemid 43052405)
6. Barnham KJ, Masters CL and Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3: 205-214, 2004..
7. Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB, and Chock PB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38: 6699-6705, 1999..
8. Benavides DR, Quinn JJ, Zhong P, Hawasli AH, DiLeone RJ, Kansy JW, Olausson P, Yan Z, Taylor JR, and Bibb JA. Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J Neurosci Off J Soc Neurosci 27: 12967-12976, 2007.. (Pubitemid 350159589)
9. Blatnik M, Frizzell N, Thorpe SR, and Baynes JW. Inactiva-tion of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible bio-marker of mitochondrial stress. Diabetes 57: 41-49, 2008..
10. Boyland E and Chasseaud LF. Glutathione S-aralkyl-transferase. Biochem J 115: 985-991, 1969..
11. Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, Park J, Eom SJ, Kim MJ, Chang TS, Choi SY, Shim J, Kim Y, Dong MS, Lee MJ, Kim SG, Ichijo H, and Choi EJ. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 276: 12749-12755, 2001..
12. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000..
13. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, and Tuveson DA. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475: 106-109, 2011..
14. Desmots F, Loyer P, Rissel M, Guillouzo A, and Morel F. Activation of C-Jun N-terminal kinase is required for glu-tathione transferase A4 induction during oxidative stress, not during cell proliferation, in mouse hepatocytes. FEBS Lett 579: 5691-5696, 2005.. (Pubitemid 41455650)
15. Dietrich JB, Mangeol A, Revel MO, Burgun C, Aunis D, and Zwiller J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neu-ropharmacology 48: 965-974, 2005.. (Pubitemid 40602604)
16. Dirr H, Reinemer P, and Huber R. X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem/FEBS 220: 645-661, 1994.. (Pubitemid 24107192)
17. Dorion S, Lambert H, and Landry J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem 277: 30792-30797, 2002.. (Pubitemid 34970777)
18. Ekhart C, Rodenhuis S, Smits PH, Beijnen JH, and Huitema AD. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment. Cancer Treat Rev 35: 18-31, 2009..
19. Fernandes AP and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74, 2004.. (Pubitemid 38063976)
20. Findlay VJ, Townsend DM, Morris TE, Fraser JP, He L, and Tew KD. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res 66: 6800-6806, 2006.. (Pubitemid 44085640)
21. Gate L, Majumdar RS, Lunk A, and Tew KD. Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways. J Biol Chem 279: 8608-8616, 2004.. (Pubitemid 38295915)
22. Ghezzi P. Regulation of protein function by glutathionyla-tion. Free Radic Res 39: 573-580, 2005..
23. Graminski GF, Kubo Y, and Armstrong RN. Spectroscopic and kinetic evidence for the thiolate anion of glutathione at the active site of glutathione S-transferase. Biochemistry 28: 3562-3568, 1989.. (Pubitemid 19121954)
24. Guindalini C, O'Gara C, Laranjeira R, Collier D, Castelo A, Vallada H, and Breen G. A GSTP1 functional variant associated with cocaine dependence in a Brazilian population. Pharmacogenet Genom 15: 891-893, 2005.. (Pubitemid 41666771)
25. Hayes JD, Flanagan JU, and Jowsey IR. Glutathione trans-ferases. Annu Rev Pharmacol Toxicol 45: 51-88, 2005..
26. Hayes JD and McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 34: 176-188, 2009..
27. Hu X, Xia H, Srivastava SK, Pal A, Awasthi YC, Zimniak P, and Singh SV. Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]-chrysene. Cancer Res 58: 5340-5343, 1998.. (Pubitemid 28551113)
28. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94, 1997.. (Pubitemid 27020316)
29. Ishimoto TM and Ali-Osman F. Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics 12: 543-553, 2002.. (Pubitemid 35177084)
30. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295: C849-C868, 2008..
31. Jones DP. Redox sensing: orthogonal control in cell cycle and apoptosis signalling. J Intern Med 268: 432-448, 2010..
32. Keppler D. Export pumps for glutathione S-conjugates. Free Radic Biol Med 27: 985-991, 1999.. (Pubitemid 29507471)
33. Litwack G, Ketterer B, and Arias IM. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature 234: 466-467, 1971..
34. Mannervik B and Danielson UH. Glutathione transferases- structure and catalytic activity. CRC Crit Rev Biochem 23: 283-337, 1988..
35. Mileo AM, Abbruzzese C, Mattarocci S, Bellacchio E, Pisano P, Federico A, Maresca V, Picardo M, Giorgi A, Maras B, Schinina ME, and Paggi MG. Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival. PloS One 4: e7254, 2009..
36. Miseta A and Csutora P. Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol Biol Evol 17: 1232-1239, 2000.. (Pubitemid 30617150)
37. Muriach M, Lopez-Pedrajas R, Barcia JM, Sanchez-Villarejo MV, Almansa I, and Romero FJ. Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by to-piramate. J Neurochem 114: 675-684, 2010..
38. Naka K, Muraguchi T, Hoshii T, and Hirao A. Regulation of reactive oxygen species and genomic stability in hema-topoietic stem cells. Antioxid Redox Signal 10: 1883-1894, 2008..
39. O'Brien M, Kruh GD and Tew KD. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J Pharmacol Exp Therapeut 294: 480-487, 2000.. (Pubitemid 30490819)
40. Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G, Adatto P, Hess K, Ali-Osman F, Groves M, Yung AW, Levin VA, Wei Q, and Bondy M. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res Off J Am Assoc Cancer Res 10: 2618-2625, 2004.. (Pubitemid 38509134)
41. Pandya U, Srivastava SK, Singhal SS, Pal A, Awasthi S, Zimniak P, Awasthi YC, and Singh SV. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochem Biophys Res Commun 278: 258-262, 2000..
42. Romero L, Andrews K, Ng L, O'Rourke K, Maslen A, and Kirby G. Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem J 400: 135-141, 2006.. (Pubitemid 44763828)
43. Ruscoe JE, Rosario LA, Wang T, Gate L, Arifoglu P, Wolf CR, Henderson CJ, Ronai Z, and Tew KD. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298: 339-345, 2001.. (Pubitemid 32574545)
44. Starke DW, Chock PB and Mieyal JJ. Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction. J Biol Chem 278: 14607-14613, 2003.. (Pubitemid 36799782)
45. Sun KH, Chang KH, Clawson S, Ghosh S, Mirzaei H, Regnier F, and Shah K. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J Neurochem 118: 902-914, 2011..
46. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54: 4313-4320, 1994.. (Pubitemid 24273141)
47. Tew KD. TLK-286: a novel glutathione S-transferase-activated prodrug. Exp Opin Investig Drugs 14: 1047-1054, 2005.. (Pubitemid 41131655)
48. Tew KD. Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem Pharmacol 73: 1257-1269, 2007.. (Pubitemid 46454398)
49. Tew KD, Manevich Y, Grek C, Xiong Y, Uys J, and Town-send DM. The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med 51: 299-313, 2011..
50. Townsend DM. S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7: 313-324, 2007..
51. Townsend DM, Manevich Y, He L, Hutchens S, Pazoles CJ, and Tew KD. Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284: 436-445, 2009..
52. Uys JD, Knackstedt L, Hurt P, Tew KD, Manevich Y, Hutchens S, Townsend DM, and Kalivas PW. Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity. Neuropsychopharmacolgy 36: 2551-2560, 2011..
53. Winterbourn CC and Hampton MB. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med 45: 549-561, 2008..
54. Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 11: 3013-3069, 2009..
55. Wu Y, Fan Y, Xue B, Luo L, Shen J, Zhang S, Jiang Y, and Yin Z. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25: 5787-5800, 2006.. (Pubitemid 44435255)
56. Xiao R, Lundstrom-Ljung J, Holmgren A, and Gilbert HF. Catalysis of thiol/disulfide exchange. Glutaredoxin 1 and protein-disulfide isomerase use different mechanisms to enhance oxidase and reductase activities. J Biol Chem 280: 21099-21106, 2005.. (Pubitemid 40805669)
57. Xiong Y, Uys JD, Tew KD, and Townsend DM. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal 15: 233-270, 2011..
58. Yin Z, Ivanov VN, Habelhah H, Tew K, and Ronai Z. Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60: 4053-4057, 2000.. (Pubitemid 30636583)